{"entity":{"type":"insider","cik":"0001821479","url":"/insider/0001821479","json_url":"/insider/0001821479.json","name":"Smith Jason Drew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":13,"first":"2021-05-18","last":"2026-02-11","span_basis":"filed_date"},"name_variants":[{"name":"Smith Jason Drew","source":"filing","n_filings":13,"first_seen":"2021-05-18","last_seen":"2026-02-11"}],"transactions":[{"id":5932164,"accession":"0001437749-26-003778","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001437749-26-003778","line_url":"/filing/0001437749-26-003778","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001821479","owner_name":"Smith Jason Drew","owner_display_name":"Smith Jason Drew","owner_url":"/insider/0001821479","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7479.0,"shares_display":"7,479","price_per_share":19.69,"price_display":"19.69","price_state":"stated","total_value":147261.51,"total_display":"147,261.51","total_whole":"147,262","shares_owned_after":55588.0,"shares_owned_after_display":"55,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-11","scope":"insider","n_lines":3},{"id":4954195,"accession":"0001437749-25-028705","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-25-028705","line_url":"/filing/0001437749-25-028705#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001821479","owner_name":"Smith Jason Drew","owner_display_name":"Smith Jason Drew","owner_url":"/insider/0001821479","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1520.0,"shares_display":"1,520","price_per_share":19.11,"price_display":"19.11","price_state":"stated","total_value":29047.2,"total_display":"29,047.20","total_whole":"29,047","shares_owned_after":43305.0,"shares_owned_after_display":"43,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-08","filed_date":"2025-09-09","scope":"insider"},{"id":4689487,"accession":"0001437749-25-023963","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-25-023963","line_url":"/filing/0001437749-25-023963#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001821479","owner_name":"Smith Jason Drew","owner_display_name":"Smith Jason Drew","owner_url":"/insider/0001821479","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7522.0,"shares_display":"7,522","price_per_share":19.14,"price_display":"19.14","price_state":"stated","total_value":143971.08,"total_display":"143,971.08","total_whole":"143,971","shares_owned_after":41492.0,"shares_owned_after_display":"41,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-28","filed_date":"2025-07-30","scope":"insider"},{"id":4055342,"accession":"0001437749-25-002685","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001437749-25-002685","line_url":"/filing/0001437749-25-002685","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001821479","owner_name":"Smith Jason Drew","owner_display_name":"Smith Jason Drew","owner_url":"/insider/0001821479","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7379.0,"shares_display":"7,379","price_per_share":11.14,"price_display":"11.14","price_state":"stated","total_value":82202.06,"total_display":"82,202.06","total_whole":"82,202","shares_owned_after":29781.0,"shares_owned_after_display":"29,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-04","scope":"insider","n_lines":3},{"id":2054869,"accession":"0001437749-24-029038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-029038","line_url":"/filing/0001437749-24-029038#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001821479","owner_name":"Smith Jason Drew","owner_display_name":"Smith Jason Drew","owner_url":"/insider/0001821479","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1521.0,"shares_display":"1,521","price_per_share":13.08,"price_display":"13.08","price_state":"stated","total_value":19894.68,"total_display":"19,894.68","total_whole":"19,895","shares_owned_after":25226.0,"shares_owned_after_display":"25,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-12","scope":"insider"},{"id":9288358,"accession":"0001437749-24-003155","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-003155","line_url":"/filing/0001437749-24-003155","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001821479","owner_name":"Smith Jason Drew","owner_display_name":"Smith Jason Drew","owner_url":"/insider/0001821479","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4993.0,"shares_display":"4,993","price_per_share":15.78,"price_display":"15.78","price_state":"stated","total_value":78789.54,"total_display":"78,789.54","total_whole":"78,790","shares_owned_after":20076.0,"shares_owned_after_display":"20,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-05","scope":"insider","n_lines":3},{"id":2713181,"accession":"0001437749-24-003018","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001437749-24-003018","line_url":"/filing/0001437749-24-003018","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001821479","owner_name":"Smith Jason Drew","owner_display_name":"Smith Jason Drew","owner_url":"/insider/0001821479","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4993.0,"shares_display":"4,993","price_per_share":15.74,"price_display":"15.74","price_state":"stated","total_value":78589.82,"total_display":"78,589.82","total_whole":"78,590","shares_owned_after":23414.0,"shares_owned_after_display":"23,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider","n_lines":3},{"id":8764926,"accession":"0001437749-23-025204","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-23-025204","line_url":"/filing/0001437749-23-025204#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001821479","owner_name":"Smith Jason Drew","owner_display_name":"Smith Jason Drew","owner_url":"/insider/0001821479","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":18.01,"price_display":"18.01","price_state":"stated","total_value":68438.0,"total_display":"68,438.00","total_whole":"68,438","shares_owned_after":18407.0,"shares_owned_after_display":"18,407","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-31","filed_date":"2023-09-05","scope":"insider"},{"id":8417675,"accession":"0001437749-23-002338","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-23-002338","line_url":"/filing/0001437749-23-002338","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001821479","owner_name":"Smith Jason Drew","owner_display_name":"Smith Jason Drew","owner_url":"/insider/0001821479","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1636.0,"shares_display":"1,636","price_per_share":10.12,"price_display":"10.12","price_state":"stated","total_value":16556.32,"total_display":"16,556.32","total_whole":"16,556","shares_owned_after":13873.0,"shares_owned_after_display":"13,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider","n_lines":2},{"id":6696623,"accession":"0001437749-22-021776","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-22-021776","line_url":"/filing/0001437749-22-021776#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001821479","owner_name":"Smith Jason Drew","owner_display_name":"Smith Jason Drew","owner_url":"/insider/0001821479","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3606.0,"shares_display":"3,606","price_per_share":7.21,"price_display":"7.21","price_state":"stated","total_value":25999.26,"total_display":"25,999.26","total_whole":"25,999","shares_owned_after":12176.0,"shares_owned_after_display":"12,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-31","filed_date":"2022-09-02","scope":"insider"},{"id":6367640,"accession":"0001209191-22-006387","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-006387","line_url":"/filing/0001209191-22-006387#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001821479","owner_name":"Smith Jason Drew","owner_display_name":"Smith Jason Drew","owner_url":"/insider/0001821479","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":414.0,"shares_display":"414","price_per_share":7.58,"price_display":"7.58","price_state":"stated","total_value":3138.12,"total_display":"3,138.12","total_whole":"3,138","shares_owned_after":7449.0,"shares_owned_after_display":"7,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-31","filed_date":"2022-02-02","scope":"insider"},{"id":5501277,"accession":"0001209191-21-067440","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-067440","line_url":"/filing/0001209191-21-067440#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001821479","owner_name":"Smith Jason Drew","owner_display_name":"Smith Jason Drew","owner_url":"/insider/0001821479","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3803.0,"shares_display":"3,803","price_per_share":12.03,"price_display":"12.03","price_state":"stated","total_value":45750.09,"total_display":"45,750.09","total_whole":"45,750","shares_owned_after":7030.0,"shares_owned_after_display":"7,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-02","scope":"insider"},{"id":5491429,"accession":"0001209191-21-033399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-033399","line_url":"/filing/0001209191-21-033399#line-1","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001821479","owner_name":"Smith Jason Drew","owner_display_name":"Smith Jason Drew","owner_url":"/insider/0001821479","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":15.71,"price_display":"15.71","price_state":"stated","total_value":39275.0,"total_display":"39,275.00","total_whole":"39,275","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001668243","name":"UroGen Pharma Ltd.","url":"/issuer/0001668243","role":"Officer (General Counsel)","n_filings":13,"first_seen":"2021-05-18","last_seen":"2026-02-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001821479","retrieved_at":"2026-08-24T01:01:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}